Trading Statement
(Thomson Reuters ONE) - For Immediate Release 22 January 2010 ReGen Therapeutics Plc ('ReGen' or 'the Company') TRADING UPDATEReGen Therapeutics Plc (AIM:RGT) announced on 7 December 2009 a comprehensiveupdate showing how business was proceeding in each market. Since then therehave been three material changes:AustraliaWe reported that Healthworld Limited were not able to import Colostrinin(TM)because of new restrictions imposed on colostrum products by the AustralianQuarantine Inspection Service (AQIS). We are pleased to announce thatHealthworld Limited has now been given a valid permit to import Colostrinin(TM)into Australia again.TurkeyAs a previously unexpected requirement our licensee Eczacibasi have been askedto provide the Turkish Authorities with samples of Colostrinin(TM) tablets,packed into blisters and branded 'Dyna' - exactly as it is proposed to importcommercial supplies. These have now been provided to Eczacibasi and they expectto receive final approval to market the product within the next few weeks.CyprusUpgraded blister packing has now been developed by Metagenics to prevent theissue of tablet discolouration that was being experienced in Cyprus. A supply ofthese has now been provided to Golgi to minimise any disruption to theirdistribution and marketing.In all other markets we are proceeding as set out in the Notice of the 7December 2009.For further information please contact:Percy LomaxReGen Therapeutics PlcTel No 020 7153 4920Roland Cornish/Felicity GeidtBeaumont Cornish LimitedTel No 020 7628 3396Nick Bealer/David ScottAlexander DavidTel No 020 7448 9820[HUG#1376147]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.01.2010 - 07:57 Uhr
Sprache: Deutsch
News-ID 1009285
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
London
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 114 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Trading Statement
"
steht unter der journalistisch-redaktionellen Verantwortung von
ReGen Therapeutics Plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
